Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Lipidomics of Adipose Tissue Thermogenesis
Mechanisms of Counterregulatory Failure
Role of ORCA in DNA replication
The Pathogenesis and Genetics of Environmental Asthma
Mechanisms of Inflammation Induced by Venous Thrombosis
Recently added grants:
Mouse Immunization/Challenge
Identification of Immunologic Mechanisms of Enhanced Ng Clearance Induced by Nm OMV-based Vaccines
Neisserial OMV Vaccines
Nanodisc-displayed Protein Vaccines
Peptide-VLP Vaccines
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67190-2-0-1
Application #
7574870
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Albert Einstein College of Medicine
$396,788
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Little, Jane /
$471,185
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant